Original Article

Safety Profile of High-Dose Statin Therapy in Geriatric Patients with Stroke

Objectives: Use of high-dose statin therapy (HDST) in patients with stroke became standard clinical practice after the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study, in which the mean age of the study population was approximately 63 years. Little data are available on the adverse effects of statins…